| Company | Therapeutic Area | Products | Target | Partner | Molecular Format | Indication | Status | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III | BLA | more |
|||||||
| Oncology | DM001 | TROP2/EGFR | Bispecific ADC | Solid Tumor |
|
|||||||||
| Oncology | DM002 | HER3/MUC1 | Bispecific ADC | Solid Tumor |
|
|||||||||
| Oncology | DM005 | EGFR/MET | Bispecific ADC | Solid Tumor |
|
|||||||||
| Oncology | DM007 | Undisclosed | Inhibitors | Solid Tumor |
|
|||||||||
| Oncology | DM008 | Undisclosed | Bispecific ADC | Solid tumor |
|
|||||||||
| Oncology | DM009 | Undisclosed | Bispecific ADC | Solid tumor |
|
|||||||||
